Companies/EU/COX

NICOX SA

Last · Paris€0.3005-0.0085 (-2.75%)stale · yahoo · 47h ago
Vol 85.6K ≈ 25.7K
Market cap€29.2M97.2M sh
P/E · TTM-10.0fwd -1.3 · eps -0.03 · loss
Beta0.53vs S&P 500
Div yield0.00%annual · TTM
52w range
€0.281€0.569
Volume85.6Ksession

Issuer

Legal nameNICOX SA
HQEurope (EU)
ListingEU COX
ISINFR0013018124
SectorHealthcare
IndustryPharmaceuticals
CurrencyEUR
Entity registrylei:969500EZGEO9W4JXR353
Employees10
AddressNicox SA Emerald Square 06410, Biot +33 4 97 24 53 00
Headline financial metrics
Revenue€7.2M
Operating income€-46.0M
Net income€-43.8M
Free cash flow€-18.5M
Operating margin-636.1%
Net margin-605.0%
Return on equity-57.9%
Period2021
Loading chart…

OpenFilings analyst

Our analyst

ANNUAL · 2022-04-29

From latest ANNUAL · 2022-04-29

  • Operating Cf Burn
  • Net Margin Sharply Negative

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -605.0%

Press & signals

3 of 5 recent
  • GlobeNewswire

    Data on Nicox's NCX 470 to be presented at AAOpt Annual Meeting 2026

  • GlobeNewswire

    Nicox Announces NCX 470 NDA in China Accepted for Review

  • GlobeNewswire

    Nicox Announces Extension of Cash Runway

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents